BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Seagen Reports Fourth Quarter and Full Year 2022 Financial Results

  Seagen Inc. (Nasdaq:SGEN) today reported financial results for the fourth quarter and year ended December 31, 2022.

  February 15, 2023

   · 

  16 min read
• Business

  Jazz Pharmaceuticals to Report 2022 Fourth Quarter and Full Year Financial Results on March 1, 2023

  Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2022 fourth quarter and full year financial results on Wednesday, March 1, 2023, after the close of the U.S. financial markets.

  February 15, 2023

   · 

  1 min read
• Biotech Beach

  Tandem Diabetes Care Announces Upcoming March 2023 Conference Presentations

  Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the following investor conferences.

  February 15, 2023

   · 

  1 min read
• Business

  Amedisys Reports Fourth Quarter and Year-End 2022 Financial Results, Issues 2023 Guidance, Announces Sale of Its Personal Care Line of Business and Signs Innovative Palliative Care at Home Partnership With BlueCross BlueShield of Tennessee

  Amedisys, Inc. reported its financial results for the three-month period and year ended December 31, 2022.

  February 15, 2023

   · 

  27 min read
• Business

  QuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results

  QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced financial results for the fourth quarter ended January 1, 2023.

  February 15, 2023

   · 

  18 min read
• Business

  Owens & Minor Announces Fourth Quarter & Full Year 2022 Earnings Release Date and Conference Call

  Owens & Minor, Inc. plans to release financial results for the fourth quarter and full year of 2022 on Tuesday, February 28, 2023, before trading begins on the New York Stock Exchange.

  February 15, 2023

   · 

  1 min read
• Drug Development

  Innovent Announces First Patient Dosed in a Phase 3 Clinical Trial (CLEAR) of Picankibart (Anti-IL23p19 Monoclonal Antibody) in Patients with Moderate-to-Severe Plaque Psoriasis

  Innovent Biologics, Group. announced that the first patient with moderate-to-severe plaque psoriasis has been successfully dosed in a Phase 3 clinical trial of picankibart, a recombinant anti-interleukin 23p19 subunit antibody injection.

  February 15, 2023

   · 

  9 min read